Walleye Trading LLC Viking Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

  • $46.7 Billion
  • Q3 2024

Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$49.84 - $70.47 $1.1 Million - $1.55 Million
22,000 Added 1100.0%
24,000 $1.52 Million
Q2 2024

Aug 14, 2024
SELL
$47.39 - $80.2 $94,780 - $160,400
-2,000 Reduced 50.0%
2,000 $106,000
Q1 2024

May 15, 2024
SELL
$17.4 - $94.5 $372,359 - $2.02 Million
-21,400 Reduced 84.25%
4,000 $328,000
Q4 2023

Feb 14, 2024
BUY
$9.24 - $19.64 $170,940 - $363,340
18,500 Added 268.12%
25,400 $472,000
Q3 2023

Nov 14, 2023
BUY
$10.92 - $16.0 $10,920 - $16,000
1,000 Added 16.95%
6,900 $76,000
Q2 2023

Aug 14, 2023
BUY
$14.84 - $24.79 $26,712 - $44,622
1,800 Added 43.9%
5,900 $95,000
Q1 2023

May 15, 2023
SELL
$8.08 - $17.33 $65,448 - $140,373
-8,100 Reduced 66.39%
4,100 $68,000
Q4 2022

Feb 14, 2023
BUY
$2.72 - $9.4 $33,184 - $114,680
12,200 New
12,200 $114,000
Q4 2019

Feb 14, 2020
BUY
$6.38 - $8.73 $12,122 - $16,587
1,900 New
1,900 $15,000
Q3 2019

Nov 14, 2019
SELL
$6.55 - $8.6 $3,275 - $4,300
-500 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$7.67 - $10.63 $1,534 - $2,126
-200 Reduced 28.57%
500 $4,000
Q1 2019

May 15, 2019
SELL
$7.58 - $9.94 $183,436 - $240,548
-24,200 Reduced 97.19%
700 $7,000
Q4 2018

Feb 14, 2019
BUY
$7.16 - $16.21 $178,284 - $403,629
24,900 New
24,900 $190,000

Others Institutions Holding VKTX

# of Institutions
473
Shares Held
66.2M
Call Options Held
5.72M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.03B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email